Sotrovimab restores neutralisation against current Omicron subvariants in patients with blood cancer
Cancer cell
; 2023.
Article
in English
| EuropePMC | ID: covidwho-2305848
ABSTRACT
Wu et al. report that patients with hematologic malignancies have reduced immunity against SARS-CoV-2 Omicron subvariants and Sotrovimab retains neutralizing capacity against all tested Omicron subvariants.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Topics:
Variants
Language:
English
Journal:
Cancer cell
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS